BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37703311)

  • 1. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
    Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
    Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
    Dickson DW; Kouri N; Murray ME; Josephs KA
    J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
    Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
    Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants.
    Lin LC; Nana AL; Hepker M; Hwang JL; Gaus SE; Spina S; Cosme CG; Gan L; Grinberg LT; Geschwind DH; Coppola G; Rosen HJ; Miller BL; Seeley WW
    Acta Neuropathol Commun; 2019 Oct; 7(1):159. PubMed ID: 31640778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology.
    Hartnell IJ; Blum D; Nicoll JAR; Dorothee G; Boche D
    Brain; 2021 Apr; 144(3):724-745. PubMed ID: 33527991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pick's disease with neuronal four-repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum.
    Ikeda C; Yokota O; Miki T; Takenoshita S; Ishizu H; Mori Y; Yamazaki K; Ozaki Y; Ueno SI; Ishihara T; Hasegawa M; Terada S; Yamada N
    Neuropathology; 2017 Dec; 37(6):544-559. PubMed ID: 28691164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.
    Kovacs GG; Rozemuller AJ; van Swieten JC; Gelpi E; Majtenyi K; Al-Sarraj S; Troakes C; Bódi I; King A; Hortobágyi T; Esiri MM; Ansorge O; Giaccone G; Ferrer I; Arzberger T; Bogdanovic N; Nilsson T; Leisser I; Alafuzoff I; Ironside JW; Kretzschmar H; Budka H
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):166-78. PubMed ID: 22471883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias.
    Kawles A; Keszycki R; Minogue G; Zouridakis A; Ayala I; Gill N; Macomber A; Lubbat V; Coventry C; Rogalski E; Weintraub S; Mao Q; Flanagan ME; Zhang H; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
    Acta Neuropathol Commun; 2024 Feb; 12(1):31. PubMed ID: 38389095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
    Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
    Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
    Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
    Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
    Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
    J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.
    Horie K; Barthélemy NR; Spina S; VandeVrede L; He Y; Paterson RW; Wright BA; Day GS; Davis AA; Karch CM; Seeley WW; Perrin RJ; Koppisetti RK; Shaikh F; Lago AL; Heuer HW; Ghoshal N; Gabelle A; Miller BL; Boxer AL; Bateman RJ; Sato C
    Nat Med; 2022 Dec; 28(12):2547-2554. PubMed ID: 36424467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
    Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
    J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.